Literature DB >> 19922888

Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study.

Martin C S Wong1, Johnny Y Jiang, Sian M Griffiths.   

Abstract

BACKGROUND: Although poor control of hypertension is a problem worldwide, most published studies of adherence to antihypertensive medications have involved only white subjects.
OBJECTIVE: This study examined levels of and factors associated with short-term adherence to beta-blocker therapy among a representative sample of ethnic Chinese patients with hypertension from a large territory in Hong Kong.
METHODS: Data for all hypertensive patients aged > or = 18 years who received a prescription for a beta-blocker at a visit to any public primary care clinic in the New Territory East cluster of Hong Kong and made at least 1 subsequent visit for a refill of this prescription between January 2004 and June 2007 were obtained from a validated clinical database generalizable to the Chinese population. The proportion of patients who were adherent to beta-blocker therapy was measured based on the medication possession ratio (MPR), calculated over 2 consecutive visits. Good adherence was defined as an MPR > or = 80%. Factors potentially associated with adherence to beta-blockers were investigated using multivariable logistic regression analysis, with adjustment for age, sex, payment status, service type, district of residence, visit type, and number of comorbidities.
RESULTS: Data were obtained for 15,918 eligible patients (62.2% female; mean age, 59.1 years). Of these patients, 81.3% were adherent to beta-blocker therapy. Factors associated with a greater likelihood of good adherence to beta-blocker therapy were age > or = 50 years (adjusted odds ratio [AOR], age 50-59 years = 1.53 [95% CI, 1.38-1.70]; AOR, age 60-69 years = 1.85 [95% CI, 1.64-2.10]; AOR, age > or = 70 years = 1.88 [95% CI, 1.66-2.12]; all, P < 0.001); fee paid versus fee waived (AOR = 1.16 [95% CI, 1.06-1.28]; P = 0.001); attendance at a family medicine specialist clinic (AOR = 1.30 [95% CI, 1.09-1.54]; P = 0.003); and follow-up visit versus new-patient visit (AOR = 2.67 [95% CI, 2.42-2.95]; P < 0.001).
CONCLUSION: Among these Chinese patients with hypertension, younger patients, those whose fees were waived, and those who were newly prescribed a beta-blocker had a greater likelihood of being nonadherent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19922888     DOI: 10.1016/j.clinthera.2009.10.004

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  6 in total

1.  The healthcare burden of hypertension in Asia.

Authors:  Chun-Na Jin; Cheuk-Man Yu; Jing-Ping Sun; Fang Fang; Yong-Na Wen; Ming Liu; Alex Pui-Wai Lee
Journal:  Heart Asia       Date:  2013-11-19

2.  β-blocker withdrawal among patients presenting for surgery from home.

Authors:  Robert B Schonberger; Carrie L Lukens; O Dicle Turkoglu; Jessica L Feinleib; Kenneth L Haspel; Matthew M Burg
Journal:  J Cardiothorac Vasc Anesth       Date:  2012-03-13       Impact factor: 2.628

3.  Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale.

Authors:  Gabrielle K Y Lee; Harry H X Wang; Kirin Q L Liu; Yu Cheung; Donald E Morisky; Martin C S Wong
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

4.  Drug adherence and the incidence of coronary heart disease- and stroke-specific mortality among 218,047 patients newly prescribed an antihypertensive medication: a five-year cohort study.

Authors:  Martin C S Wong; Wilson W S Tam; Clement S K Cheung; Harry H X Wang; Ellen L H Tong; Antonio C H Sek; Bryan P Y Yan; N T Cheung; Stephen Leeder; C M Yu; Sian Griffiths
Journal:  Int J Cardiol       Date:  2012-11-20       Impact factor: 4.164

5.  Medication adherence to first-line antihypertensive drug class in a large Chinese population.

Authors:  Martin C S Wong; Wilson W S Tam; Clement S K Cheung; Ellen L H Tong; Antonio C H Sek; N T Cheung; Stephen Leeder; Sian Griffiths
Journal:  Int J Cardiol       Date:  2012-05-03       Impact factor: 4.164

6.  Predictors of the incidence of all-cause mortality and deaths due to diabetes and renal diseases among patients newly prescribed antihypertensive agents: a cohort study.

Authors:  Martin C S Wong; Wilson W S Tam; Harry H X Wang; Clement S K Cheung; Ellen L H Tong; Antonio C H Sek; N T Cheung; Bryan P Y Yan; C M Yu; Stephen R Leeder; Sian M Griffiths
Journal:  Int J Cardiol       Date:  2013-07-26       Impact factor: 4.164

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.